Relmada Therapeutics (RLMD) Short Interest
Nasdaq • RLMD • US75955J4022
As of Oct 26, 2026, ORTEX estimated 13.8% of free float sold short, 7.5 days to cover, cost to borrow 0.52%. Sign up for live short interest data.
Nasdaq • RLMD • US75955J4022
As of Oct 26, 2026, ORTEX estimated 13.8% of free float sold short, 7.5 days to cover, cost to borrow 0.52%. Sign up for live short interest data.
This page tracks how heavily Relmada Therapeutics (Nasdaq:RLMD) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Relmada Therapeutics (Nasdaq: RLMD) has a market capitalization of $455.48M. Last close $4.27 (as of 2026-11-11); 52-week range $2.97 to $8.00. ORTEX data as of 2026-10-26: short interest was 13.82% of free float, 7.5 days to cover and the average cost to borrow was 0.52%. Sign up for live short interest data.